| Golden Years Nursing Home | |
| 7348 North West Street, Falcon, North Carolina 28342 | |
| (910) 980-1271 | |
| Name | Golden Years Nursing Home |
|---|---|
| Location | 7348 North West Street, Falcon, North Carolina |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 58 |
| Occupancy Rate | 74.66% |
| Medicare ID (CCN) | 345367 |
| Legal Business Name | Liberty Healthcare Group, Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1588618045 |
| Organization Name | LIBERTY HEALTHCARE GROUP LLC |
| Doing Business As | LIBERTY HEALTHCARE SERVICES OF GOLDEN YEARS NURSING CENTER, LLC |
| Address | 7348 North West Street, Falcon, NC 28342 |
| Phone Number | 910-980-1271 |
News Archive
E2F5 is a member of the E2F transcription factor family, and plays a key role in cell growth and proliferation. Overexpression of E2F5 has been reported in various human cancers, but not in liver cancer, and its biological implication is largely unknown. It is not known whether E2F5 plays a tumor suppressor role or an oncogenic role.
Researchers from City of Hope, a world-renowned comprehensive cancer center and independent biomedical research institution, have developed a synthetic DNA molecule that is programmed to jump-start the immune system to eradicate genetically distinct types of prostate cancer.
Scientists at The Scripps Research Institute have discovered a new role for an enzyme involved in cell death. Their study shows how the enzyme, called RIPK3, relays signals between the cell's mitochondria "powerhouses" and the immune system.
Research led by UNC School of Medicine student Wesley Stepp, PhD, shows how more detailed genetic testing of head and neck tumors could lead to more personalized treatments for patients.
› Verified 4 days ago
| NPI Number | 1912040379 |
| Organization Name | LIBERTY HEALTHCARE GROUP LLC |
| Doing Business As | GOLDEN YEARS NURSING CENTER |
| Address | 7348 N West St, Falcon, NC 28342 |
| Phone Number | 910-980-1271 |
News Archive
E2F5 is a member of the E2F transcription factor family, and plays a key role in cell growth and proliferation. Overexpression of E2F5 has been reported in various human cancers, but not in liver cancer, and its biological implication is largely unknown. It is not known whether E2F5 plays a tumor suppressor role or an oncogenic role.
Researchers from City of Hope, a world-renowned comprehensive cancer center and independent biomedical research institution, have developed a synthetic DNA molecule that is programmed to jump-start the immune system to eradicate genetically distinct types of prostate cancer.
Scientists at The Scripps Research Institute have discovered a new role for an enzyme involved in cell death. Their study shows how the enzyme, called RIPK3, relays signals between the cell's mitochondria "powerhouses" and the immune system.
Research led by UNC School of Medicine student Wesley Stepp, PhD, shows how more detailed genetic testing of head and neck tumors could lead to more personalized treatments for patients.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
E2F5 is a member of the E2F transcription factor family, and plays a key role in cell growth and proliferation. Overexpression of E2F5 has been reported in various human cancers, but not in liver cancer, and its biological implication is largely unknown. It is not known whether E2F5 plays a tumor suppressor role or an oncogenic role.
Researchers from City of Hope, a world-renowned comprehensive cancer center and independent biomedical research institution, have developed a synthetic DNA molecule that is programmed to jump-start the immune system to eradicate genetically distinct types of prostate cancer.
Scientists at The Scripps Research Institute have discovered a new role for an enzyme involved in cell death. Their study shows how the enzyme, called RIPK3, relays signals between the cell's mitochondria "powerhouses" and the immune system.
Research led by UNC School of Medicine student Wesley Stepp, PhD, shows how more detailed genetic testing of head and neck tumors could lead to more personalized treatments for patients.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 27.94 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 13.94 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 75.76 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.92 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.35 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.65 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.15 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.41 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 6.72 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 57.5 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.05 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.21 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.77 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.89 | 95.98 |